Table 1 Subject Demographics data are expressed as means (SD)
From: T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease
| Â | COPD N = 14 | Smokers N = 10 | HNS N = 10 | COPD N = 10 IF | Smokers N = 11 IF |
|---|---|---|---|---|---|
Sex (F/M) | 4/10 | 3/7 | 5/5 | 4/6 | 5/6 |
Age (years) | 66.9 (7.3) | 62.4 (20.6) | 39.5 (22.4) | 65.2 (6.8) | 66.1 (8.6) |
Gold Stage (1/2/3) | 0/13/1 | N/A | N/A | 3/6/1 | N/A |
FEV1 (L) | 1.8 (0.6) | 2.0 (0.9) | 3.4 (1.2) | 2.01 (0.5) | 2.06 (0.5) |
FEV1% predicted | 62 (12) | 98 (19) | 100 (15) | 70.4 (11.5) | 86.4 (19.3) |
FEV1/FVC ratio | 56 (13.8) | 77 (5.7) | 83 (6.0) | 60.8 (11.1) | 73.8 (7.7) |
Pack year history | 40.7 (26.4) | 37.2 (28.5) | 0 | 49.2 (39.7) | 62.3 (29.5) |
Current/Ex smoker | 5/9 | 5/5 | N/A | 9/1 | 11/0 |
ICS Users | 6 | 0 | 0 | 2 | 0 |
BAL Yield (mls) | 91.0 (76.3) | 115 (109) | 190 (131) | N/A | N/A |
Total Cell Yield/ml (× 106) | 0.23 | 0.28 | 0.13 | N/A | N/A |
Total Lymphocytes (%) | 6.9 | 6.6 | 7.6 | N/A | N/A |